Vivimed Labs Ltd Locks at Lower Circuit With 1.9% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, declined by Rs 0.12 to close at Rs 6.21, hitting the lower circuit limit set by the exchange at 2% for the day. This price band capped the maximum daily loss, effectively freezing trading at the floor price. The total traded volume was 40,360 shares, with a turnover of just ₹0.00253 crore, reflecting the mechanical effect of the circuit breaker rather than a reduction in selling interest. The persistent presence of sellers without matching buyers created a clear case of unfilled supply, a hallmark of lower circuit events. This scenario is particularly concerning for a micro-cap stock like Vivimed Labs Ltd, where liquidity constraints amplify exit difficulties. Vivimed Labs Ltd’s market capitalisation stands at a modest ₹51.49 crore, underscoring the limited depth in trading.

Delivery and Volume Analysis

Delivery volumes on 8 Sep 2026 surged to 15,810 shares, a 35.73% increase over the 5-day average delivery volume. On a lower circuit day, rising delivery volume signals genuine liquidation by holders rather than speculative short-selling. This indicates that shareholders are offloading actual holdings, pointing to capitulation or forced selling rather than intraday trading activity. The total traded volume on the circuit day was relatively low, consistent with the price lock, but the elevated delivery volume confirms that the selling pressure is substantive and not merely technical. Vivimed Labs Ltd’s delivery data thus paints a picture of genuine exit attempts by investors — is this capitulation or just the beginning for Vivimed Labs Ltd?

Intraday Price Action

The stock opened at Rs 6.35, trading above the previous close, but steadily declined throughout the session to close at the lower circuit price of Rs 6.21. This intraday fall of approximately 2.2% from the high to the circuit low reflects a steady erosion of demand as sellers overwhelmed buyers. The absence of any meaningful bounce or recovery during the day highlights the persistent selling pressure. The gradual descent rather than a sharp gap-down suggests that sellers were active throughout the session, but buyers remained absent, allowing the circuit breaker to intervene and halt further declines. Does the intraday pattern suggest exhaustion or a prelude to further weakness?

Moving Averages and Trend Context

Technically, Vivimed Labs Ltd is positioned below its 5-day and 200-day moving averages but remains above the 20-day, 50-day, and 100-day averages. This mixed moving average configuration indicates short-term weakness amid longer-term support levels. The stock’s failure to hold above the shorter-term averages confirms the recent selling pressure, but the presence above medium-term averages suggests some residual technical support. The current lower circuit event accelerates the downtrend, but the technical profile leaves open the question of whether the stock will find a base near these medium-term averages or continue lower — does the technical profile of Vivimed Labs Ltd show any nearby support, or is more downside likely?

Liquidity and Exit Risk

As a micro-cap stock with a market capitalisation of ₹51.49 crore, Vivimed Labs Ltd faces significant liquidity constraints. The total turnover of ₹0.00253 crore on the circuit day is minimal, and the stock’s liquidity allows for a trade size of effectively zero at 2% of the 5-day average traded value. This means that any sizeable position faces severe exit friction, as sellers cannot find buyers at or above the circuit price. The unfilled supply at Rs 6.21 highlights the risk of multi-day circuit locks, where sellers remain trapped unable to exit their holdings. This liquidity trap is a common challenge for small and micro-cap stocks hitting lower circuits, compounding the selling pressure and raising questions about the depth of the sell-off — how deep is the exit problem for Vivimed Labs Ltd and what would need to change for normal trading to resume?

Fundamental Context

Vivimed Labs Ltd operates in the Pharmaceuticals & Drugs industry, a sector that often experiences volatility linked to regulatory developments and market sentiment. While fundamentals are not the focus of this price action, the micro-cap status and sector dynamics contribute to the stock’s sensitivity to selling pressure. The current market cap of ₹51.49 crore places it firmly in the micro-cap category, where trading volumes and liquidity are typically limited.

Conclusion: Severity and Liquidity Caveats

The lower circuit lock at Rs 6.21, combined with rising delivery volumes and a mixed but weakening moving average profile, signals a significant selling event for Vivimed Labs Ltd. The unfilled supply and low liquidity create a challenging exit environment for holders, raising the risk of prolonged circuit locks. While the stock remains above some medium-term moving averages, the short-term technical weakness and genuine liquidation pressure suggest that the selling momentum is not yet fully exhausted. After a 1.9% single-day loss at lower circuit, is Vivimed Labs Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Liquidity and Exit Risk Warning: As a micro-cap stock, Vivimed Labs Ltd faces heightened liquidity risk. Lower circuit events can trap sellers for multiple sessions, as buyers remain absent at floor prices. Investors should be aware that exit opportunities may remain limited until demand returns to the stock.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →